2m 2m 2m 2m 2m 2m 2m
- $4.1MMarket Cap
- -83.23%1-Year Change
- Drug Manufacturers - Specialty & GenericIndustry
Sunshine Biophm (SBFM)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 56
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
Why Sunshine Biopharma (SBFM) Stock Dropped After Hours Today
Sunshine Biopharma (NASDAQ:SBFM) shares fell 5.17% to $0.30 in after-hours trading following the announcement of a one-for-ten reverse stock split effective June 1, 2026. The reverse split was undertaken to regain compliance with Nasdaq's minimum bid price requirement. The stock has declined 77.99% over the past 12 months and currently has a market capitalization of approximately $5.18 million.
05/29/2026, 2:16 AM • Benzinga
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
Sunshine Biopharma, Inc. operates as a pharmaceutical company that engages in the research and development of life-saving medicines in various therapeutic areas, including oncology and antivirals in the United States and Canada. The company is developing SBFM-PL4, a protease inhibitor for the treatment of SARS coronavirus infections; and K1.1 mRNA, a lipid nano-particle for liver cancer. It also offers Essential 9, an amino acids capsules; Calcium-Vitamin D supplement under the Essential Calcium-Vitamin D brand name; and L-Citrulline and Taurine products. In addition, the company provides various generic prescription drugs for osteoporosis, cardiovascular, antipsychotic, antibacterial, hypertension, anti-inflammatory, allergy, antibiotic, central nervous system, diabetes, urology, antifungal, antimalarial, oncology, gastroenterology, dermatology, smoking cessation, cholelithiasis, anticonvulsant, urology, women's health, acid reflux, and anticonvulsant indications. Sunshine The company is based in Fort Lauderdale, Florida.
Key Executives
- Steve N. Slilaty
- Camille Sebaaly
- Michel Roy
- Robert G. Ferreira
- Malek Chamoun
Current Ownership Distribution
- Insiders243.1M (98.22%)
- Institutions3.0M (1.23%)
- Mutual Funds1.4M (0.55%)
- Other0 (0.00%)